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Abstract
Introduction—Evidence suggests prenatal phthalate exposures may have neurodevelopmental 
consequences. Our objective was to investigate prenatal exposure to phthalates and cognitive 
development in a cohort of young urban children.
Materials and Methods—We recruited pregnant women in New York City from 1998 to 2002 
and measured concentrations of nine phthalate metabolites in urine collected in late pregnancy. We 
administered a neurodevelopmental screening instrument, the Bayley Scales of Infant 
Development II (BSID-II), to children who returned for follow-up at approximately 24 months 
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(n=276). We estimated associations between phthalate metabolite concentrations in maternal urine 
and BSID-II indices (Mental Development Index (MDI), Psychomotor Development Index (PDI)).
Results—We observed no associations between phthalate metabolite concentrations and 
performance on the MDI or PDI in boys and girls combined. We did, however, observe evidence 
of effect measure modification by sex. We observed several negative associations between 
metabolite concentrations and both MDI and PDI scores among girls, suggesting poorer 
performance across multiple metabolites, with estimates equal to a 2-3 point decrease in score per 
ln-unit increase in creatinine-standardized metabolite concentration. Conversely, we observed 
multiple weakly positive associations among boys, equal to a 1-2 point increase in score per ln-
unit increase in metabolite concentration. The strongest associations were for the metabolites 
mono-n-butyl phthalate, monoisobutyl phthalate, monobenzyl phthalate, and mono(3-
carboxylpropyl) phthalate (MCPP).
Conclusions—Girls of mothers with higher urinary concentrations of MCPP and metabolites of 
dibutyl phthalates had lower MDI scores on the BSID-II. These same biomarker concentrations 
were often associated with improved scores among boys. We observed similar results for MnBP, 
MCPP, and MBzP on the PDI. Given the prevalence of phthalate exposures in reproductive aged 
women, the implications of potential neurotoxicity warrant further investigation.
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1. Introduction
Phthalates are high production volume chemicals with many industrial applications and are 
used to produce a diverse array of commercial and consumer products, including packaging 
and storage materials, medical supplies, medication coatings, building materials, cosmetics, 
and personal care products. Phthalates are weakly bound to these products and can easily 
contaminate other materials and the environment. Human exposure to phthalates occurs via 
dermal absorption, ingestion of certain medications and contaminated foods, inhalation, and 
intravenously through medical tubing and devices (NRC 2008; CHAP 2014). Inside the 
body, phthalates are rapidly metabolized and are primarily excreted in urine (Koch et al. 
2006; M. J. Silva et al. 2003; Hogberg et al. 2008). While phthalates do not accumulate 
significantly in the body, their ubiquity and consistent use results in frequent exposure. 
Biomonitoring surveys of the United States population consistently detect phthalate 
metabolites in greater than 90% of those surveyed (CDC 2015). Vulnerable populations, 
such as women of reproductive age, infants and young children, and racial and ethnic 
minorities, may be more exposed to phthalates than persons of other demographic strata 
(CDC 2015; Manori J. Silva et al. 2003).
Certain phthalates are biologically active compounds that exhibit endocrine disrupting 
properties, including anti-androgenicity (CHAP 2014; NTP 2000) and associations with 
thyroid hormone concentrations (Boas et al. 2010; Kuo et al. 2015; Johns et al. 2015), both 
of which can impair the development and function of physiologic systems (NRC 2008; 
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CHAP 2014; Miodovnik et al. 2014). The hormonal environment in utero regulates many 
neurodevelopmental processes (Gore et al. 2014) and alterations in maternal endocrine 
function (de Escobar et al. 2004; Haddow et al. 1999) or fetal sex hormone concentrations 
during pregnancy (Gore et al. 2014) can affect neurologic development in offspring. 
Consequently, it is hypothesized that maternal exposure to phthalates during the prenatal 
period could affect neurologic development in offspring.
To date, several epidemiologic studies have investigated the relationship between prenatal 
exposure to phthalates and child cognitive (Factor-Litvak et al. 2014; Whyatt et al. 2012; 
Polanska et al. 2014; Tellez-Rojo et al. 2013; Kim et al. 2011) and behavioral (Whyatt et al. 
2012; Engel et al. 2010; Swan et al. 2010; Lien et al. 2015; Gascon et al. 2015; Kobrosly et 
al. 2014) development. These studies suggest potential neurodevelopmental consequences of 
prenatal phthalate exposures, though there has been limited overlap in the 
neurodevelopmental outcomes assessed and child ages included across studies. Among the 
studies addressing childhood cognitive development among children two to three years of 
age, only two considered differential responses by child sex, and among these, the results are 
somewhat conflicting. These data gaps and inconsistencies hinder a synthesis of the 
evidence.
We investigated prenatal exposure to phthalates and cognitive and psychomotor development 
in children at approximately 24 months of age in the Mount Sinai Children's Environmental 
Health cohort.
2. Methods
2.1 The Mount Sinai Children's Environmental Health Center birth cohort
Between March 1998 and March 2002 the Mount Sinai Children's Environmental Health 
Center enrolled primiparous women seeking prenatal care from the Mount Sinai Diagnostic 
and Treatment Center and two private practices located on the Upper East Side of 
Manhattan. Women were eligible to participate if they were pregnant with a singleton 
pregnancy, had had their first prenatal care visit prior to 26 weeks of gestation, did not have 
a serious chronic condition (i.e., diabetes, hypertension, thyroid disease), did not acquire a 
serious pregnancy complication, and did not report consuming more than two alcoholic 
beverages per day or use illicit drugs. Of 1,450 women who satisfied initial eligibility 
criteria and approached for enrollment, 479 enrolled and completed a baseline questionnaire 
that collected information pertaining to pregnancy characteristics, demographics, lifestyle 
factors, and environmental and occupational exposures. Mothers gave birth at Mount Sinai 
School of Medicine (MSSM) and birth outcome information were available from the MSSM 
perinatal database. After birth, a total of 404 mother-child pairs were eligible to continue 
participation (Berkowitz et al. 2002; Berkowitz et al. 2003).
We invited mothers and children to return for follow-up evaluations at the Mount Sinai 
Hospital at approximately 24 months (n=276). At this time, we collected additional 
information on the child and home environment, and administered the Bayley Scales of 
Infant Development-II (BSID-II).
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The Mount Sinai Children's Environmental Health Study was approved by the Institutional 
Review Board of the Mount Sinai School of Medicine. This analysis was approved by the 
Institutional Review Board of the University of North Carolina at Chapel Hill. The 
involvement of the Centers for Disease Control and Prevention (CDC) laboratory was 
determined not to constitute engagement in human subjects research.
2.2 Measurement of phthalate metabolite concentrations
We collected a spot urine sample from mothers during a prenatal care visit that occurred 
between 25 and 40 weeks gestation (Median: 31, IQR: 29-34). We stored these urine 
samples at -20°C until analysis, and shipped them overnight on dry ice to the CDC in 
Atlanta, GA for measurement of concentrations of nine phthalate metabolites: mono(2-
ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), 
mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), mono(2-ethyl-5-carboxypentyl) phthalate 
(MECPP), mono-n-butyl phthalate (MnBP), mono-isobutyl phthalate (MiBP), monoethyl 
phthalate (MEP), monobenzyl phthalate (MBzP), and mono(3-carboxypropyl) phthalate 
(MCPP). Metabolite concentrations were expressed in micrograms per liter. We summed 
four metabolites (MEHP, MEHHP, MECPP, MEOHP) of di(2-ethylhexyl) phthalate (DEHP) 
to produce a molar sum (∑DEHP) expressed in micromoles per liter. Analytical procedures 
used to measure phthalate metabolite concentrations in the Mount Sinai Children's 
Environmental Health Study have been described before (Silva et al. 2008; Kato et al. 2005). 
We measured urinary dilution using creatinine concentration, and we excluded participants 
(n=2) who had extremely dilute urine (creatinine <10 mg/dL).
We imputed metabolite concentrations below the limit of detection (LOD) with values equal 
to the LOD divided by the square root of two (Lubin et al. 2004). We natural-log (ln) 
transformed the creatinine-standardized metabolite concentrations in statistical models to 
improve the normality of their distributions.
2.3 Measurement of neurodevelopment
One of four trained examiners administered the Bayley Scales for Infant Development-II 
(BSID-II) in either English or Spanish to children who returned at the 24-month examination 
(n=276). The BSID-II is a validated and widely-used neurodevelopmental screening 
instrument designed to measure cognitive and psychomotor development in children ages 1 
to 42 months. The BSID-II produces two indices: the Mental Development Index (MDI) that 
assesses memory, habituation, problem solving, early number concepts, generalization, 
classification, vocalizations, language, and social skills, and the Psychomotor Development 
Index (PDI) that assesses gross- and fine-motor skills. The MDI and PDI normative scores 
are standardized to have a population mean of 100 and standard deviation of 15; valid 
MDI/PDI scores range between 50 and 150 (Bayley 1993). Participating children with a 
valid score on either the MDI or PDI were included in our analysis (n=258).
2.4 Statistical analyses
We calculated descriptive statistics to quantitatively describe the baseline population 
(n=404) and the population included in the present analysis (n=258). We used t-tests and 
chi-square tests of association to assess differences in characteristics between these two 
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populations. We calculated descriptive statistics to characterize distributions of the phthalate 
metabolite concentrations, and similarly calculated descriptive statistics of the children's 
MDI and PDI scores and compared these between certain informative strata using t-tests.
To investigate our primary hypothesis, we used general linear models to estimate the change 
in MDI or PDI score per unit increase in ln-transformed creatinine standardized metabolite 
concentrations. Dependent variables in all models were either MDI or PDI scores modeled 
as continuous variables. We adjusted for the following confounding variables selected on the 
basis of a directed acyclic graph (Greenland et al. 1999; Rothman et al. 2008): maternal race 
(White/Black/Hispanic/other), pre-pregnancy Body Mass Index (BMI, kg/m2), maternal age 
in years, maternal education (less than high school/high school/some college/college 
graduate), supportive qualities of child's home environment (Home Observation for 
Measurement of the Environment (HOME) score) (Caldwell BM 1979), child's age at testing 
in months, maternal marital status (single/married/living with partner), and duration of 
breastfeeding in months. We used covariate-adjusted standardization plus covariate 
adjustment to account for urine dilution and adjust for potential confounding by creatinine, a 
method proposed by O'Brien et al. (O'Brien et al. 2015). Specifically, we used maternal age, 
BMI, education, race, and sex of the child to predict creatinine and compute the creatinine 
ratio used to standardize the phthalate metabolite concentrations. We also included 
creatinine as an adjustment variable in all analyses. This procedure is expected to account 
for variation in creatinine attributable to the adjustment factors, and also block potential 
confounding by associations between creatinine and the outcome (here, neurologic 
development).
We estimated these associations in the full cohort and among boys and girls separately by 
fully stratifying by sex. To conduct a formal test of heterogeneity of associations by sex, we 
specified a model that included product terms between sex and all covariates (which is 
functionally equivalent to stratification by sex) and evaluated the sex-metabolite product 
term. We considered there to be potentially meaningful effect measure modification if the 
product term p-value was below 0.10.
We conducted additional sensitivity analyses. First, we repeated our analyses using the 
standard creatinine-adjusted approach described by Barr et al. (Barr et al. 2005). Second, 
because race was a strong predictor of phthalate exposure and BSID-II scores in our 
population, we repeated analyses restricted to Black and Hispanic participants (n=199). And 
third, to assess the validity of our linearity assumptions and investigate alternative dose-
response shapes, we estimated associations between MDI or PDI scores and tertile of 
creatinine-standardized metabolite concentrations. We did not additionally adjust for urinary 
creatinine in categorical analyses.
We used SAS 9.4 (Cary, NC) for statistical analyses.
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3. Results
3.1 Study population
Mothers who participated in the Mount Sinai Children's Environmental Health Study were 
diverse with respect to age, race, and educational attainment (Table 1). As compared to 
White mothers (n=56), non-White (Black, Hispanic, or other; n=202) mothers were younger 
(median age 21 years non-White vs. 33 years White), less likely to have graduated from 
college (7% non-White vs. 97% White), and less likely to be married at enrollment (11% 
married non-White vs. 91% married White). We observed no important differences in the 
distributions of important characteristics between the baseline cohort (n=404) and the subset 
included in our analyses (n=258).
3.2 Phthalate metabolite concentrations
In Table 2 we provide descriptive statistics of the phthalate metabolite concentrations we 
measured in third trimester maternal urine. With the exception of MEHP, all metabolites 
were detected in >95% of the mothers. We observed that phthalate metabolite concentrations 
among non-White mothers in our population were 1.4 to 3.1 times concentrations among 
White mothers (Supplemental Table 1). Correlations among phthalate metabolite 
concentrations were moderate to strong: Spearman correlation coefficients for metabolites of 
different parent compounds ranged from 0.33 to 0.80, while Spearman correlations for the 
four metabolites of DEHP ranged from 0.81 to 0.98 (Supplemental Table 2). Creatinine 
standardization had little impact on the distributions of the metabolite concentrations (not 
shown).
3.3 Performance on the BSID-II
Children's ages at time of testing ranged from 22 to 42 months (Median: 25; IQR: 23-27). 
Children's MDI scores ranged from 50 to 126 (Median: 88; IQR: 78-98) and PDI scores 
ranged from 50 to 129 (Median: 95; IQR: 87-103). We observed that distributions of MDI 
scores varied considerably across strata of race and maternal education, whereas 
distributions of PDI scores were homogenous across these characteristics (Table 3).
3.4 Associations between metabolite concentrations and BSID-II scores
In the full cohort, we observed no strong associations between individual phthalate 
metabolites or metabolite sums (i.e., ∑DEHP) and performance on the MDI or PDI. We did, 
however, observe strong evidence of effect measure modification by sex: associations were 
generally null or negative among girls (suggesting neurodevelopmental harm) and null or 
positive among boys (suggesting neurodevelopmental benefit). Beta estimates were often 
larger and less precise for girls than for boys. Phthalate-MDI associations differed most 
strongly for MCPP, MBzP, and metabolites of dibutyl phthalates, while phthalate-PDI 
associations differed most strongly for MnBP, MBzP, and MCPP (all interaction p < 0.10).
Concentrations of MnBP, MiBP, and MCPP in maternal urine during pregnancy were 
negatively associated with MDI scores among girls, such that a unit increase in metabolite 
concentrations was associated with a 2 to 2.5 point decrease in MDI score (Table 4a). 
Conversely, similar increases in maternal urinary concentrations of MnBP, MCPP, and 
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MBzP were associated with a 1.5 to 2 point increase in MDI score among boys. These 
estimates were slightly more precise for boys than for girls, with standard errors (SEs) 
ranging from 0.71 to 1.01 for boys and 0.82 to 1.19 for girls - a result of there being more 
boys than girls in our study population.
Concentrations of MnBP, MCPP, and MBzP in maternal urine during pregnancy were 
associated with poorer performance on the PDI among girls, with an estimated 2 to 3 point 
decrease in PDI score per unit increase in metabolite concentration (Table 4b). Conversely, a 
unit increase in MnBP concentration was associated with a 1.92 (95% CI: 0.31, 3.54) point 
increase in PDI score among boys. These beta estimates were, again, more precise among 
boys than girls, with SEs ranging from 0.70 to 0.98 for boys and 0.86 to 1.24 for girls.
In sensitivity analyses, models using the traditional creatinine adjustment approach (without 
standardization) described by Barr et al. yielded no material differences in associations’ 
magnitudes and confidence intervals (data not shown) (Barr et al. 2005). We also considered 
models that additionally adjusted for maternal IQ and found little differences in estimates of 
association, although precision was decreased due to a substantial reduction in sample size 
as a result of 15% of the population missing maternal IQ. Upon restriction to Black and 
Hispanic participants (n=199) we observed that the direction and magnitude of most of our 
associations remained unchanged, though estimates became somewhat less precise in this 
smaller sample size (Supplemental Table 3). The results of our categorical analyses 
supported our assumption of linearity in some instances, but not all. Some associations 
demonstrated threshold-type (e.g., MCPP and MDI/PDI among girls) and non-monotonic 
(e.g., MiBP and MDI among girls) exposure-response shapes (Supplemental Table 4). 
Because of the small size of each tertile, however, these estimates were very imprecise (SEs 
from 2.55 to 3.02). In light of this imprecision and to facilitate comparison with other 
published reports, we opted to focus on the linear estimates described above.
4. Discussion
4.1 Primary results
Girls of mothers with higher urinary concentrations of MCPP and metabolites of dibutyl 
phthalates had lower MDI and PDI scores on the BSID-II at age 24 months. Also, higher 
MBzP concentrations were associated with lower PDI scores among girls. These same 
biomarker concentrations were often associated with improved performance among boys, of 
a smaller magnitude but often greater precision due to the larger number of boys in our study 
population.
Our study of primiparous urban women adds to the growing number of observational studies 
of prenatal phthalate exposure and cognitive development in young children (Whyatt et al. 
2012; Polanska et al. 2014; Tellez-Rojo et al. 2013; Gascon et al. 2015). With few 
exceptions, investigators who reported results for girls and boys separately generally 
observed weakly negative associations among girls and null or weakly positive associations 
among boys. Figure 1 provides comparisons of our results with two such studies, including 
Tellez-Rojo et al. who investigated prenatal phthalate exposure in relation to performance on 
the BSID-II among 135 children ages 2 to 3 years living in Mexico City between 1997 and 
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2003, and Whyatt et al. who investigated this association among 319 children at 
approximately 3 years of age living in New York City between 1996 and 2006 (Figure 1) 
(Whyatt et al. 2012; Tellez-Rojo et al. 2013). The implications of these differences in 
associations among boys and girls are unclear, but are echoed in sexually dimorphic 
associations across a range of outcomes in relation to phthalate exposure, including 
anogenital distance (Swan et al. 2015), behavior (Engel et al. 2010; Swan et al. 2010; 
Kobrosly et al. 2014; Swan et al. 2015), and growth (Valvi et al. 2015; Kim et al. 2016; 
Buckley et al. 2016; Maresca et al. 2015). Additional experimental evidence would improve 
our understanding of how phthalates might influence sexually dimorphic neurologic 
development in human populations, although plausible biological mechanisms have been 
noted (Miodovnik et al. 2011).
4.2 Biological Mechanism
Although a specific mechanism linking maternal phthalate exposure to neurologic 
development is not yet established, extensive evidence suggests that phthalates can interfere 
with systems and processes essential to the development of the fetal brain and nervous 
system (CHAP 2014; Miodovnik et al. 2014; Lyche et al. 2009). One hypothesis is that 
phthalates and/or their metabolites directly interact with sex-hormones, either in the mother 
or the developing fetus. The plausibility of this mechanistic relationship is supported by 
consistent observations of antiandrogenic effects exposure to some phthalates in boys and 
the frequent observations of sex-specific outcomes in observational studies, including our 
own (NRC 2008; CHAP 2014; Miodovnik et al. 2014). Although direct mechanistic support 
for the relevance of this pathway for the developing brain and nervous system is lacking, the 
importance of sex hormones in brain development is well-described (Gore et al. 2014; 
Nguon et al. 2005), although the impact of prenatal anti-androgenic chemical exposures on 
the brain development of female offspring is an understudied area. However, the 
consequences of an altered hormonal environment on fetal brain development, though 
unclear, might be expected to differ between boys and girls. Another hypothesis contends 
that phthalate exposure affects thyroid function in the mother or fetus —an important 
determinant of neurodevelopment in offspring (de Escobar et al. 2004; Haddow et al. 1999). 
In support of this hypothesis are observational studies that have reported associations 
between phthalate exposure and thyroid function in pregnant women (Johns et al. 2015; 
Sathyanarayana et al. 2014; Huang et al. 2007) and children (Boas et al. 2010), and there is 
strong evidence from animal models that phthalates and their metabolites can disrupt the 
production and function of certain thyroid hormones (CHAP 2014; Miodovnik et al. 2014; 
Lyche et al. 2009). In addition to any endocrine-mediated effects, some phthalates and their 
metabolites are reported to interact with peroxisome proliferator-activated receptors, a class 
of nuclear receptors involved in many physiologic processes central to neurodevelopment, 
including cellular reproduction and differentiation (Miodovnik et al. 2014; Lyche et al. 
2009). Additionally prenatal phthalate exposures may be associated with gestational 
duration and fetal growth (Marie et al. 2015), which in turn are strongly related to 
neurologic development. It is therefore biologically plausible that maternal exposure to 
phthalates during pregnancy could affect neurologic development in offspring.
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4.3 Strengths and Limitations
Our study possesses several strengths. First, the Mount Sinai Children's Environmental 
Health Center enrolled a racially and socioeconomically diverse urban cohort and, as such, 
represents a wide range of potential phthalate exposure profiles. Second, our study was 
restricted to primiparous women and collected detailed information on important 
sociodemographic qualities, such as the child's home environment, which improved control 
of confounding by these important predictors of neurodevelopment. Third, the longitudinal 
nature of our study permits temporal ordering of the exposure-outcome relationship. Lastly, 
the urine samples were collected during the sensitive prenatal period, an etiologically 
significant period for brain development.
Our study also possesses certain limitations. Phthalates have relatively short biological half-
lives, and the single spot urine sample we collected during the third trimester may not be 
representative of participants’ exposure to phthalates over the entire course of pregnancy. 
Other investigators have reported weak to moderate correlations between phthalate 
metabolite concentrations measured in urine at different times in pregnancy, which vary 
depending on the specific phthalate in question; higher molecular weight phthalates such as 
DEHP tend to demonstrate greater variability than lower molecular weight phthalates, such 
as DBPs (Adibi et al. 2008; Braun et al. 2012). We suspect any bias resulting from 
measurement error of phthalate metabolite concentrations to be non-differential with respect 
to important qualities (i.e., child's neurologic development, phthalate exposure, confounding 
variables). Second, over a third of our baseline population did not return for 24-month 
follow-up which introduces the possibility of selection bias. However, we identified no 
notable differences between women who did and did not return for follow-up with respect to 
the characteristics we measured at baseline. Similarly, the participation rate at baseline for 
our study was low (33%), which potentially limits the generalizability of our results or 
possibly introduced bias; we did not collect information on non-participants and cannot 
speculate as to the nature of such bias. Third, although the BSID-II is a validated and 
widely-used neurologic instrument with appreciable test-retest and inter-rater reliability 
(Tieman et al. 2005; O'Grady and Dusing 2015), its greatest predictive validity is at the 
extremes of the performance distribution. Additionally, the MDI and PDI are summary 
measures of complex neurodevelopmental qualities and they cannot be used to make 
inferences about specific physiologic pathways or mechanisms.
Lastly, the associations we observed could have been influenced by uncontrolled or residual 
confounding. Although we controlled for multiple factors including maternal race, HOME 
Score, maternal education, and other factors, there may be important unmeasured factors 
that we did not include. One plausible source of residual confounding is by other correlated 
neurotoxicants, or correlated phthalate metabolites, because we estimated associations for 
each metabolite individually. Despite the potential for such uncontrolled confounding, the 
effect estimates produced by the single-metabolite models displayed considerable variability, 
even for correlated metabolites on the same outcome (e.g., MDI in girls), which suggests 
that our results were not overly influenced by such confounding. Additionally, in other 
analyses within the Mount Sinai cohort, confounding by co-exposure to other phthalates was 
found to be minimally influential (Buckley et al. 2015). Another potential source of residual 
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confounding is income and/or material wealth. Specifically, material wealth is associated 
with patterns of personal consumption, which are related to phthalate exposures (Schettler 
2006), and also ability to provide a supportive environment for a child's neurologic 
development. We attempted to control for such confounding by including proxy variables, 
such as educational attainment, marital status, race, and HOME score in our models, though 
other more directly related measures (e.g., income) could have potentially improved our 
analyses. We suspected our population had marked socioeconomic differences by race, and 
repeated our analyses among Black and Hispanic participants only to assess whether our 
results were consistent among this presumably more socioeconomically homogenous 
population. In this analysis, we observed similar associations to results in the full cohort, 
suggesting residual confounding by race (and presumably material wealth) was modest.
5. Conclusions
In a diverse population of urban mother-child pairs, we found evidence that maternal 
exposure to phthalates in late pregnancy was associated with her child's mental and 
psychomotor development, and observed decrements in girls but not boys. Specifically, 
greater concentrations of MCPP (a non-specific metabolite of several phthalates), MBzP, and 
MiBP were associated with poorer performance on the MDI among girls and improved 
performance among boys. We observed similar trends for MnBP, MCPP, and MBzP on the 
PDI. The results of our observational study and others like it suggest that prenatal exposure 
to certain phthalates may influence neurodevelopment in young children, and consequently 
that efforts to reduce phthalate exposure among pregnant women are prudent.
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Figure 1. 
a. Comparisons of point estimates and 95% confidence intervals for associations between 
phthalate metabolite concentrations in maternal urine during pregnancy and offspring's 
performance on the MDI among girls in three prospective birth cohort studies.
b. Comparisons of point estimates and 95% confidence intervals for associations between 
phthalate metabolite concentrations in maternal urine during pregnancy and offspring's 
performance on the MDI among boys in three prospective birth cohort studies.
c. Comparisons of point estimates and 95% confidence intervals for associations between 
phthalate metabolite concentrations in maternal urine during pregnancy and offspring's 
performance on the PDI among girls in three prospective birth cohort studies.
d. Comparisons of point estimates and 95% confidence intervals for associations between 
phthalate metabolite concentrations in maternal urine during pregnancy and offspring's 
performance on the PDI among boys in three prospective birth cohort studies.
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Table 1
Demographic characteristics of participants in the Mount Sinai Children's Environmental Health Study, 
1998-2002.
Original cohort (n=404) Analysis population (n=258)
Characteristic Median (IQR) n (%) Median (IQR) n (%) p-Valuea
Maternal age at enrollment (years) 22 (19-29) 22 (19-30) 0.2
Body mass index (kg/m2) 23 (20-25) 23 (20-25) 0.9
Maternal race/ethnicity
    White 86 (21) 56 (22) 0.9
    Black 112 (28) 70 (27)
    Hispanic 200 (50) 129 (50)
    Other 6 (1) 3 (1)
Maternal Education
    < High school 118 (29) 74 (29) 0.9
    High school 83 (21) 53 (21)
    Some college 103 (26) 65 (25)
    > College degree 98 (24) 66 (26)
Marital status at enrollment
    Married 117 (29) 73 (28) 0.4
    Living with father of child 98 (24) 58 (22)
    Single 189 (47) 127 (49)
Smoke during pregnancy
    No 337 (83) 215 (83) 1.0
    Yes 67 (17) 43 (17)
Alcohol during pregnancy
    No 337 (85) 217 (86) 0.5
    Yes 59 (15) 35 (14)
Child's sex
    Boy 220 (54) 140 (54) 0.9
    Girl 184 (46) 118 (46)
Breastfeeding duration (months) - 1.5 (0-6)
HOME score (total) - 39 (36-41)
Abbreviations: IQR, Interquartile range; HOME, Home Observation for Measurement of the Environment.
ap-Value for comparison between full cohort and analysis population: t-tests were used for comparisons of continuous measures; Chi-Square tests 
were used for comparisons of categorical measures.
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